Redsense receives positive Final Notice regarding novel optical monitoring – will obtain patent approval in Sweden
Redsense Medical AB announces the receipt of a Final Notice with regard to the patent application for the second invention related to the Company’s smart wound care technology for optical measuring of blood and exudate. The Final Notice expresses PRV’s intent to approve the application under the condition that certain modifications are made no later than 4 May 2020.On 2 September 2019, Redsense Medical submitted a patent application for a ‘method and device for monitoring a measurement object’. The application relates to a novel stand-alone invention that supports the existing wound care